Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: Creator · seated real-member story. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
Ro's ad opens on an objection a lot of viewers share: no insurance coverage for GLP-1s. Julia answers it from her own experience, saying she still managed to pay out of pocket, which makes the price claim feel personal rather than corporate. The couch setting and direct-to-camera delivery read like a friend explaining what she did. She also walks through the steps (found out she qualified online, medication shipped to her door), and the on-screen text attributes both the cash price and the weight-loss average to Ro's disclosures, with the membership fee noted.
She says the pill is affordable, but the ad never shows a price, so the core answer to her opening question is left for the landing page. There's also no reason to act now. If you make one like this, put the actual cash price on screen when the creator mentions it (with the membership fee next to it), so the viewer who shares her insurance situation gets the full answer in the ad.
It names a common objection in the first line, so viewers in the same spot stay to hear the answer.
Her experience answers the objection, and the text qualifies the price claim.
This adds specifics, attributed and qualified on screen.
Walking through the steps makes the process feel easy to picture before the call to action.
No stated price in the voiceover. The creator frames the Wegovy pill as affordable when paying cash, and on-screen text notes it's the lowest cash price on Ro with an added membership fee.
The ad sends viewers to Ro's quiz entry page, the strongest rung of the landing-page ladder because it starts an assessment right away. The GLP-1 pill answer matches the product Julia names, and the top bar's lowest-prices claim echoes her affordability point. What the page doesn't do is speak to her opening objection, since nothing on the entry screen mentions paying without insurance. A line under the question noting that cash pricing is available would finish the answer she started. It's one of 71 ads in the Fluid library that land here.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.